Perfusion
Basxter Novacor Division, Oakland, CA, USA.
Published: July 2000
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/026765910001500411 | DOI Listing |
J Heart Lung Transplant
November 2005
Heart Transplant Program, St. Luke's Medical Center, Milwaukee, Wisconsin 53215, USA.
We compared the survival outcomes, left ventricular assist device (LVAD)-related hospitalization, stroke, infection, panel reactive antibody, and blood product use data among 13 Novacor and 51 HeartMate system recipients. Stroke was significantly higher in Novacor patients, as was blood product use at the time of heart transplantation, likely due to long-term anti-coagulation, while the LVAD-related hospitalization and infections did not differ between the 2 groups. A positive panel reactive antibody was seen more among the HeartMate patients, but did not have a significant clinical impact and may not represent a true allosensitization.
View Article and Find Full Text PDFJ Cardiovasc Nurs
November 2005
Stanford University Medical Center, Stanford Hospital and Clinics, Rm. H0105 MC 5221, 300 Pasteur Drive, Stanford, CA 94305, USA.
The first bridge to transplant with a left ventricular assist device (LVAD) was preformed over 20 years ago. Since that time, the devices have continued to evolve and now patients are being supported with devices as an alternative to transplantation. The primary indication of end-stage heart failure remains the same but increased knowledge about patient selection, the timing of implant, and patient management have contributed to improved outcomes with decreasing adverse events.
View Article and Find Full Text PDFVerh K Acad Geneeskd Belg
December 2004
Departement Heelkundige en Anesthesiologische Wetenschappen Afdeling Cardiale Heelkunde--UZ Gasthuisberg Herestraat 49-B 3000 Leuven.
The most important bio-prosthetic organs in cardiovascular medicine are artificial heart valve prostheses and blood pumps. Cardiac valve prostheses can be divided in 'mechanical' and 'biological' valves. Mechanical prostheses are entirely made of artificial materials and require a meticulous anticoagulation therapy.
View Article and Find Full Text PDFJ Heart Lung Transplant
June 2003
Department of Cardiothoracic Surgery, Mount Sinai School of Medicine/New York University, New York, New York 10029, USA.
Background: The Novacor implantable, electrically powered, wearable, left ventricular assist device (LVAD) has been used as a bridge to transplantation at our institution since 1994. Recent changes in protocol have resulted in a decreased incidence of infections, thromboembolism, and mortality.
Methods: We reviewed the medical records of all 43 patients who received implantable LVADs at the Mount Sinai Medical Center.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.